Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.
Endometrial Cancer
Multidisciplinary Team Board decision change, MDT decision for adjuvant treatment (Rate of adjuvant treatment change), 2 years (study completion)
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.